Cargando…

Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review

Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 may have a mild presentation, with few symptoms, or progress to a severe condition, characterized by generalized inflammation, systemic microvascular involvement,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yugar-Toledo, Juan Carlos, Yugar, Louise Buonalumi Tacito, Sedenho-Prado, Luis Gustavo, Schreiber, Roberto, Moreno, Heitor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229057/
https://www.ncbi.nlm.nih.gov/pubmed/37260945
http://dx.doi.org/10.3389/fcvm.2023.1162837
_version_ 1785051156107493376
author Yugar-Toledo, Juan Carlos
Yugar, Louise Buonalumi Tacito
Sedenho-Prado, Luis Gustavo
Schreiber, Roberto
Moreno, Heitor
author_facet Yugar-Toledo, Juan Carlos
Yugar, Louise Buonalumi Tacito
Sedenho-Prado, Luis Gustavo
Schreiber, Roberto
Moreno, Heitor
author_sort Yugar-Toledo, Juan Carlos
collection PubMed
description Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 may have a mild presentation, with few symptoms, or progress to a severe condition, characterized by generalized inflammation, systemic microvascular involvement, coagulopathy, and pulmonary and cardiovascular complications. Men present with more severe symptoms than women, especially men who are older and who present with comorbidities such as hypertension, diabetes mellitus, and a history of atherosclerotic diseases. Owing to its association with endothelial dysfunction, inflammation, thrombosis, and microvascular obstruction, SARS-CoV-2 infection can cause lesions in several organs, including the myocardium and the coronary arterial bed, which can result in clinical manifestations involving the cardiovascular system. In this mini review, we summarize the effects of SARS-CoV-2 infection on the cardiovascular system in both children and adults and characterize the various clinical manifestations associated with this disease.
format Online
Article
Text
id pubmed-10229057
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102290572023-05-31 Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review Yugar-Toledo, Juan Carlos Yugar, Louise Buonalumi Tacito Sedenho-Prado, Luis Gustavo Schreiber, Roberto Moreno, Heitor Front Cardiovasc Med Cardiovascular Medicine Coronavirus disease 2019 (COVID-19) is a viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 may have a mild presentation, with few symptoms, or progress to a severe condition, characterized by generalized inflammation, systemic microvascular involvement, coagulopathy, and pulmonary and cardiovascular complications. Men present with more severe symptoms than women, especially men who are older and who present with comorbidities such as hypertension, diabetes mellitus, and a history of atherosclerotic diseases. Owing to its association with endothelial dysfunction, inflammation, thrombosis, and microvascular obstruction, SARS-CoV-2 infection can cause lesions in several organs, including the myocardium and the coronary arterial bed, which can result in clinical manifestations involving the cardiovascular system. In this mini review, we summarize the effects of SARS-CoV-2 infection on the cardiovascular system in both children and adults and characterize the various clinical manifestations associated with this disease. Frontiers Media S.A. 2023-05-16 /pmc/articles/PMC10229057/ /pubmed/37260945 http://dx.doi.org/10.3389/fcvm.2023.1162837 Text en © 2023 Yugar-Toledo, Yugar, Sedenho-Prado, Schreiber and Moreno. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Yugar-Toledo, Juan Carlos
Yugar, Louise Buonalumi Tacito
Sedenho-Prado, Luis Gustavo
Schreiber, Roberto
Moreno, Heitor
Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review
title Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review
title_full Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review
title_fullStr Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review
title_full_unstemmed Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review
title_short Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review
title_sort pathophysiological effects of sars-cov-2 infection on the cardiovascular system and its clinical manifestations—a mini review
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229057/
https://www.ncbi.nlm.nih.gov/pubmed/37260945
http://dx.doi.org/10.3389/fcvm.2023.1162837
work_keys_str_mv AT yugartoledojuancarlos pathophysiologicaleffectsofsarscov2infectiononthecardiovascularsystemanditsclinicalmanifestationsaminireview
AT yugarlouisebuonalumitacito pathophysiologicaleffectsofsarscov2infectiononthecardiovascularsystemanditsclinicalmanifestationsaminireview
AT sedenhopradoluisgustavo pathophysiologicaleffectsofsarscov2infectiononthecardiovascularsystemanditsclinicalmanifestationsaminireview
AT schreiberroberto pathophysiologicaleffectsofsarscov2infectiononthecardiovascularsystemanditsclinicalmanifestationsaminireview
AT morenoheitor pathophysiologicaleffectsofsarscov2infectiononthecardiovascularsystemanditsclinicalmanifestationsaminireview